| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | SAREPTA THERAPEUTICS INC | 332,300 | 12,820,000 | 0.64% | ||
| 52 | NEXTERA ENERGY PARTNERS LP | 423,750 | 12,649,000 | 0.63% | ||
| 53 | Atlantica Yield plc | 655,500 | 12,645,000 | 0.63% | ||
| 54 | Linear Technology Corp | 292,600 | 12,427,000 | 0.62% | ||
| 55 | ACADIA PHARMACEUTICALS INC COM | 334,700 | 11,932,000 | 0.60% | ||
| 56 | EOG RES INC | 144,800 | 10,250,000 | 0.51% | ||
| 57 | ULTRAGENYX PHARMACEUTICAL INC COM | 87,400 | 9,805,000 | 0.49% | ||
| 58 | TESARO INCORPORATED | 180,000 | 9,418,000 | 0.47% | ||
| 59 | KITE PHARMA INCORPORATED | 148,600 | 9,157,000 | 0.46% | ||
| 60 | DBV TECHNOLOGIES S A | 249,600 | 9,063,000 | 0.45% | ||
| 61 | AIRCASTLE LTD | 428,600 | 8,953,000 | 0.45% | ||
| 62 | LIGAND PHARMACEUTICALS INC | 80,000 | 8,674,000 | 0.43% | ||
| 63 | PATTERN ENERGY GROUP INC | 408,950 | 8,551,000 | 0.43% | ||
| 64 | ALNYLAM PHARMACEUTICALS INC | 90,000 | 8,473,000 | 0.42% | ||
| 65 | BIOMARIN PHARMACEUTICAL INC | 75,000 | 7,857,000 | 0.39% | ||
| 66 | SAGE THERAPEUTICS INC | 125,900 | 7,340,000 | 0.37% | ||
| 67 | CASTLIGHT HEALTH INC COM CL B | 1,708,600 | 7,296,000 | 0.36% | ||
| 68 | NATUS MEDICAL INC. | 148,900 | 7,155,000 | 0.36% | ||
| 69 | PROTHENA CORP PLC | 104,800 | 7,138,000 | 0.36% | ||
| 70 | NEUROCRINE BIOSCIE COM USD0.001 | 125,000 | 7,071,000 | 0.35% | ||
| 71 | SPARK THERAPEUTICS INCORPORATED | 150,000 | 6,797,000 | 0.34% | ||
| 72 | SUPERNUS PHARMACEUTICALS INC | 498,000 | 6,693,000 | 0.33% | ||
| 73 | CELLDEX THERAPEUTICS INC NEW | 420,500 | 6,593,000 | 0.33% | ||
| 74 | CERNER CORP | 108,200 | 6,510,000 | 0.33% | ||
| 75 | BLUEPRINT MEDICINES CORP COM | 246,500 | 6,493,000 | 0.32% | ||
| 76 | TG THERAPEUTICS INC COM | 537,600 | 6,414,000 | 0.32% | ||
| 77 | SERES THERAPEUTICS INC | 178,200 | 6,253,000 | 0.31% | ||
| 78 | DYNAVAX TECHNOLOGIES CORP | 250,000 | 6,040,000 | 0.30% | ||
| 79 | ACCELERON PHARMA INC | 123,500 | 6,022,000 | 0.30% | ||
| 80 | CEMPRA INC | 184,900 | 5,756,000 | 0.29% | ||
| 81 | REPLIGEN CORP COM | 202,000 | 5,715,000 | 0.29% | ||
| 82 | APPLIED GENETIC TECHNOL CORP | 279,100 | 5,694,000 | 0.28% | ||
| 83 | VOYAGER THERAPEUTICS INC | 250,000 | 5,475,000 | 0.27% | ||
| 84 | ORMAT TECHNOLOGIES INC | 150,000 | 5,471,000 | 0.27% | ||
| 85 | STEMLINE THERAPEUTICS INC | 851,400 | 5,372,000 | 0.27% | ||
| 86 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 165,000 | 5,334,000 | 0.27% | ||
| 87 | GW PHARMACEUTICALS PLC | 73,500 | 5,104,000 | 0.26% | ||
| 88 | XENCOR INC COM | 344,000 | 5,029,000 | 0.25% | ||
| 89 | Tracon Pharmaceuticals Inc | 517,700 | 4,784,000 | 0.24% | ||
| 90 | CIDARA THERAPEUTICS INC | 264,000 | 4,530,000 | 0.23% | ||
| 91 | DICERNA PHARMACEUTICALS INC | 377,000 | 4,475,000 | 0.22% | ||
| 92 | VERTEX PHARMACEUTICALS INC | 34,600 | 4,354,000 | 0.22% | ||
| 93 | ONCOMED PHARMACEUTICALS INC COM | 190,000 | 4,283,000 | 0.21% | ||
| 94 | ATRICURE INC | 180,000 | 4,039,000 | 0.20% | ||
| 95 | JUNO THERAPEUTICS INC COM | 90,000 | 3,957,000 | 0.20% | ||
| 96 | INSMED INC | 210,000 | 3,812,000 | 0.19% | ||
| 97 | IMMUNE DESIGN CORP | 180,000 | 3,614,000 | 0.18% | ||
| 98 | UNIQURE NV | 174,900 | 2,893,000 | 0.14% | ||
| 99 | CYTOMX THERAPEUTICS INC COM | 100,000 | 2,087,000 | 0.10% | ||
| 100 | ACCURAY INCORPORATED COM | 306,200 | 2,067,000 | 0.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-16-000010, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
